4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-22-008369
Options or other derivatives
- Chief Development Officer acquired 247,841 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bigora Sian Chief Development Officer | 2022-04-01 | Grant or award · Restricted Stock Units | +247,841 | 302,766 | D: show line 1 in the form |
Loading xslF345X03/doc1.xml…